Literature DB >> 24410098

Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery.

Beeravelli Sudhakar, J N Ravi Varma, K V Ramana Murthy1.   

Abstract

BACKGROUND: The goal of effective treatment for dermal fungal infections could be highly beneficial by the delivery of antifungal drugs on skin from liposomal application. Topical delivery involves minimizing the flux of the drug through the skin while maximizing its retention on the skin. The aim of the present work was the investigation of the effects of lipids and cholesterol for the development of liposomal formulations as potential carriers for antifungal agent terbinafine HCl. Phospholipon 90H (hydrogenated phosphatidylcholine) and dimyristoylglycero-3-phosphocholine (DMPC) along with cholesterol were used for preparation of liposomes by ethanol injection method and characterized for drug content, entrapment efficiency, size, zetapotential, vesicle morphology, stability, FTIR, in vitro and ex vivo drug retention studies.
RESULTS: Drug entrapment ranged between 39.46±0.91% to 70.39±0.71%. Vesicles showed good morphological characters with a narrow size distribution, in the size range of 206.9 to 344.8 nm. Gum karaya gel loaded with liposomal dispersion showed prolonged drug retention on the rat skin during ex vivo studies compared to liposomal dispersion and gum karaya plain gel loaded with drug.
CONCLUSION: The prolonged retention of drug by the gum karaya gel loaded with liposomal dispersion could effectively exhibit the antifungal activity for prolonged periods for cutaneous delivery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24410098     DOI: 10.2174/1567201810666140109113830

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  4 in total

Review 1.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 2.  Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy.

Authors:  Shivani Verma; Puneet Utreja
Journal:  Asian J Pharm Sci       Date:  2018-08-16       Impact factor: 6.598

3.  Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.

Authors:  Zhongyuan Wang; Yue Zhao; Yan Jiang; Wei Lv; Lin Wu; Baoyan Wang; Lingyan Lv; Qunwei Xu; Hongliang Xin
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

4.  Pharmacokinetic and pharmacodynamic studies of etodolac loaded vesicular gels on rats by transdermal delivery.

Authors:  Nimmathota Madhavi; Beeravelli Sudhakar; K V N Suresh Reddy; Jayanthi Vijaya Ratna
Journal:  Daru       Date:  2018-09-11       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.